Open the mobile version, with barcode scanning
Class II Terminated

MethyLPREDNISolone Acetate Injectable Suspension, USP, 200mg/5mL (40 mg/mL), 5 mL multi-dose vial, Rx only, MFG: Teva Pharma USA, NDC 0703-0043-01

Why: cGMP deviations: Temperature abuse

Company
Mckesson Medical-Surgical Inc. Corporate Office
Richmond, VA, United States
Reported
Jun 15, 2022
Recall started
Apr 13, 2022
Ended
Nov 30, 2023
Where sold
USA nationwide.
Amount
65 cartons/1 vial each
Full product description
MethyLPREDNISolone Acetate Injectable Suspension, USP, 200mg/5mL (40 mg/mL), 5 mL multi-dose vial, Rx only, MFG: Teva Pharma USA, NDC 0703-0043-01
Lots / codes affected
McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.